Moreover, fluoxetine represses NLRP3 inflammasome stimulation in macrophages as well as the hippocampus in mice models of long-term mild-stress, implying an encouraging therapeutic scenario for therapy of NLRP3 inflammasome-associated depression [77]. Here, NLRP3 is linked to depressive symptom measurement.